Today, Semler Scientific announced It has increased its Bitcoin holdings. The company acquired 185 Bitcoin between May 23 and June 3 for $ 20 million with an average purchase price of $ 107,974 per Bitcoin, using the income of its market supply program (ATM).
“We continue to grow our Bitcoin arsenal using the operating cash flow and procedures for debt and capital financing,” said Semler Scientific Eric Semler president Eric Semler. “And we are excited to launch the Semler Scientific Dashboard today on our website to provide the public regularly updated information about our Bitcoin holdings and other key metrics.”
Since the launch of the ATM program in April 2025, Semler has raised approximately $ 136.2 million under the sale agreement of more than 3.6 million common shares.
As of June 3, 2025, Semler has 4,449 bitcoin that were acquired for an amount of $ 410.0 million, with an average purchase price of $ 92,158 per Bitcoin. At the time of writing, the market value of these holdings is around $ 446.2 million.
Eric Semler in X published: “SMLR acquires 185 bitcoins for $ 20 million and has generated a BTC yield of 26.7% YTD. It now has $ 4,449 BTC.”
Semler Scientific uses BTC’s performance as a key performance indicator (KPI) to help evaluate the performance of its Bitcoin strategy. Until the year to date, the company has achieved a BTC yield of 26.7%.
“Semler Scientific believes that this KPI can be used to complement the understanding of an investor of the Semler Scientific’s decision to finance the purchase of Bitcoin issuing additional actions of its ordinary shares or convertible instruments for common actions,” said the 8-K form.
In Q1 Fy2025, Semler Scientific reported a difficult quarter. The income reached $ 8.8 million, a 44% decrease year after year. Operating expenses increased to $ 39.9 million of $ 8.9 million last year, mainly due to a contingent responsibility of $ 29.8 million linked to the possible liquidation with the Department of Justice. This led to an operational loss of $ 31.1 million, compared to a gain of $ 7.0 million in the first quarter of 2024.
“Our medical care business is seeing green sprouts of the cardiovascular products line that we present to our large business client base this year,” said Semler Scientific CEO Doug Murphy-Chutorian. “We expect the growth and effective generation of these products and services approved by the FDA, which will be added to our Bitcoin Treasury strategy.”
